These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 29703034)

  • 1. Usefulness of 18F-FDG PET/CT for evaluating response of ocular adnexal lymphoma to treatment.
    Fujii H; Tanaka H; Nomoto Y; Harata N; Oota S; Isogai J; Yoshida K
    Medicine (Baltimore); 2018 Apr; 97(17):e0543. PubMed ID: 29703034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of
    Wang W; Ni X; Tang T; Wang J; Li Y; Song X
    Br J Radiol; 2022 Feb; 95(1130):20210635. PubMed ID: 34919440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
    Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
    Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Positron emission tomography in the detection and staging of ocular adnexal lymphoproliferative disease.
    Valenzuela AA; Allen C; Grimes D; Wong D; Sullivan TJ
    Ophthalmology; 2006 Dec; 113(12):2331-7. PubMed ID: 16996604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of positron emission tomography in staging ocular adnexal lymphomas and evaluating their response to therapy.
    Gayed I; Eskandari MF; McLaughlin P; Pro B; Diba R; Esmaeli B
    Ophthalmic Surg Lasers Imaging; 2007; 38(4):319-25. PubMed ID: 17674923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of FDG-PET in the Diagnosis and Staging of Ocular Adnexal Lymphoproliferative Disease.
    English JF; Sullivan TJ
    Orbit; 2015; 34(5):284-91. PubMed ID: 26308502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of 18FDG PET scan in staging of ocular adnexal lymphomas: a large single-center experience.
    Zanni M; Moulin-Romsee G; Servois V; Validire P; Bénamor M; Plancher C; Rouic LL; Dendale R; Vincent-Salomon A; Asselain B; Sahli R; Decaudin D
    Hematology; 2012 Mar; 17(2):76-84. PubMed ID: 22664045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bosio G; Bertoli M; Giubbini R; Bertagna F
    J Neurooncol; 2018 Feb; 136(3):577-583. PubMed ID: 29147860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of decreased uptake of 18F-fluorodeoxyglucose in the cerebral cortex of patients with intracranial non-Hodgkin's lymphoma lesions through PET/CT.
    Zhang Q; Tian T; Wang L; Qiu H; Li D
    Biomed Pharmacother; 2016 Dec; 84():1331-1336. PubMed ID: 27810790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 18F-FDG PET/CT in gastric MALT lymphoma: a bicentric experience.
    Albano D; Bertoli M; Ferro P; Fallanca F; Gianolli L; Picchio M; Giubbini R; Bertagna F
    Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):589-597. PubMed ID: 27619357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
    Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
    World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT in splenic marginal zone lymphoma.
    Albano D; Giubbini R; Bertagna F
    Abdom Radiol (NY); 2018 Oct; 43(10):2721-2727. PubMed ID: 29500652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary mucosa-associated lymphoid tissue lymphoma:
    Albano D; Borghesi A; Bosio G; Bertoli M; Maroldi R; Giubbini R; Bertagna F
    Br J Radiol; 2017 Nov; 90(1079):20170311. PubMed ID: 28830222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [18F-FDG PET/CT in ocular and orbital abnormalities not only neopastic: comparison with traditional imaging].
    Altini C; Niccoli Asabella A; Ferrari C; Rubini D; Merenda N; Rubini G
    Recenti Prog Med; 2015 Aug; 106(8):393-401. PubMed ID: 26228862
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [¹⁸F]FDG-positron emission tomography coregistration with computed tomography scans for radiation treatment planning of lymphoma and hematologic malignancies.
    Terezakis SA; Hunt MA; Kowalski A; McCann P; Schmidtlein CR; Reiner A; Gönen M; Kirov AS; Gonzales AM; Schöder H; Yahalom J
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):615-22. PubMed ID: 20933343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Novel Melanin-Targeted
    Wang Y; Wang X; Zhang J; Zhang X; Cheng Y; Jiang F
    Korean J Radiol; 2024 Aug; 25(8):742-748. PubMed ID: 39028010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of 18F-fluoro-2-deoxyglucose positron emission tomography and gallium-67 citrate scintigraphy for detecting malignant lymphoma.
    Shen YY; Kao A; Yen RF
    Oncol Rep; 2002; 9(2):321-5. PubMed ID: 11836600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Value of
    Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
    Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.